Carregant...
Ertugliflozin in the treatment of type 2 diabetes mellitus
More than 422 million people worldwide have diabetes, with 90–95% having type 2 diabetes (T2D). Glycemic control of T2D has demonstrated reductions in microvascular complications but recent data have demonstrated improvements in macrovascular outcomes with sodium–glucose cotransporter 2 (SGLT2) inhi...
Guardat en:
| Publicat a: | Drugs Context |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioExcel Publishing Ltd
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7707814/ https://ncbi.nlm.nih.gov/pubmed/33293984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-7-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|